Lancashire and South Cumbria
Formulary
Formulary
10 Musculoskeletal and joint diseases
10-01-02-02 Local corticosteroids injections
| Methylprednisolone Acetate with Lidocaine Depo-Medrone® with lidocaine |
|
Formulary
|
Suspension for injection lidocaine hydrochloride 10mg per 1ml, Methylprednisolone acetate 40mg per 1ml |
|
Links
BSPED Adrenal Insufficiency Consensus Guidelines
LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway- LSCMMG: Primary Care Constipation Guidelines
- MHRA DSU April 2019: Belimumab (Benlysta): increased risk of serious psychiatric events seen in clinical trials
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- MHRA: Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration
- NHSE: National Patient Safety Alert – Steroid Emergency Card to support early recognition and treatment of adrenal crisis in adults
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people
- NICE TA397: Belimumab for treating active autoantibody-positive systemic lupus erythematosus
- NICE TA752:Belimumab for treating active autoantibody-positive systemic lupus erythematosus
- NICE TA806: Belimumab for treating lupus nephritis (terminated appraisal)